iifl-logo-icon 1

Unichem Laboratories Ltd Half Yearly Results

697.15
(-1.54%)
Feb 12, 2025|12:09:45 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Sept-2024Mar-2024Sept-2023Mar-2023Sept-2022

Gross Sales

908.59

946.29

838.82

704.59

638.43

Excise Duty

0

0

0

0

0

Net Sales

908.59

946.29

838.82

704.59

638.43

Other Operating Income

0

0

0

0

0

Other Income

12.65

17.42

14.17

21.46

17.05

Total Income

921.24

963.72

852.98

726.06

655.48

Total Expenditure

807.57

953.81

802.03

764.42

662.73

PBIDT

113.67

9.91

50.95

-38.36

-7.25

Interest

8.82

10.17

12.49

9.61

7.7

PBDT

104.85

-0.26

38.46

-47.97

-14.95

Depreciation

56.86

64.93

58.23

60.46

52.98

Minority Interest Before NP

0

0

0

0

0

Tax

1.42

5.1

2.84

4.85

5.67

Deferred Tax

6.82

-1.69

2.55

-5.09

20.44

Reported Profit After Tax

39.75

-68.6

-25.16

-108.19

-94.04

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

39.75

-68.6

-25.16

-108.19

-94.04

Extra-ordinary Items

0

-57.61

0

-33.54

-3.09

Adjusted Profit After Extra-ordinary item

39.75

-10.99

-25.16

-74.65

-90.95

EPS (Unit Curr.)

5.65

0

-3.57

0

-13.36

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

14.08

14.08

14.08

14.08

14.08

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

12.51

1.04

6.07

-5.44

-1.13

PBDTM(%)

-

-

-

-

-

PATM(%)

4.37

-7.24

-2.99

-15.35

-14.72

Unichem Labs.: Related NEWS

Unichem Labs Q3 Profit Drops 20.5% YoY, Revenue Up 14.5%
6 Feb 2025|10:48 PM

Revenue increased by 14.5% to ₹533 crore from ₹466 crore the previous year.

Read More
Unichem Labs plans to consolidate US generic formulations bizz
23 Sep 2024|03:02 PM

Bayshore Pharmaceuticals is a 100% subsidiary of Unichem Laboratories' parent firm, Ipca Laboratories Ltd.

Read More
Unichem Labs Goa facility gets 5 observations from USFDA
16 Jul 2024|11:11 AM

According to the corporation, the observations have no influence on business continuity or supplies to the US market.

Read More
Top 10 stocks for today - 16th July, 2024
16 Jul 2024|08:47 AM

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.